GKIM
VIVO

GW&K Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

GW&K Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-422,555
Closed -$9.98M – 227
2013
Q3 		$9.98M Buy
422,555
+29,952
+8% +$699K 0.3% 105
2013
Q2 		$8.44M Buy
+392,603
New +$8.47M 0.31% 113

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

GW&K Investment Management's VIVO Position: Q4 2013 in Review

GW&K Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2013, closing a stake of 422,555 shares — an estimated $9.98M sold.

GW&K Investment Management first reported a position in VIVO in Q2 2013 and held it in 2 quarters. The position peaked at $9.98M in Q3 2013. 170 funds tracked by Wall St. Rank hold VIVO as of Q4 2013.

  • GW&K Investment Management reported no remaining Meridian Bioscience Inc position as of Q4 2013 after selling out during the quarter.
  • GW&K Investment Management sold 422,555 Meridian Bioscience Inc shares in Q4 2013, an estimated $9.98M.
  • GW&K Investment Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 2 quarters.
  • GW&K Investment Management's Meridian Bioscience Inc position peaked at $9.98M in Q3 2013.
  • 170 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2013.

Based on GW&K Investment Management's 13F filing for Q4 2013, filed 13 Jan 2014.